However, the ONLY reason any physician would prescribe Lumigan for cosmesis would be to circumvent insurance policy reimbursement guidelines regarding covered and non-covered medical indications. That is not malpractice, it is insurance fraud.
In my most recent post, I was clearly talking about a hypothetical self-pay patient, so we can set aside the insurance-related issues since the patient in question doesn’t have any.
I’m surprised you assume that, just because Lumigan and Latisse are the same chemical entity, a judge and jury in a malpractice case stemming from a severe adverse reaction to Lumigan use on eyelashes would not be swayed by the fact that Lumigan is an unapproved product for such use. At the very least, the off-label use would give the plaintiff’s lawyer an opening to paint the doctor as careless and arrogant for unnecessarily flouting the FDA label.
You may know a lot about medicine, but it sounds as though you haven’t spent much time with lawyers. I suppose that’s a good thing :- )
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”